Clinical trial

Neuroprotection With Phenytoin in Optic Neuritis

NCT01451593

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-11-01

PhasePHASE2

Study timeline

Study start (unknown)2011-11-01Date precision: month

Registry last updated2015-09-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Optic Neuritisunresolved

Multiple Sclerosisunresolved

Interventions

PhenytoinDRUG · verified · RxNorm: phenytoin

PlaceboDRUG

Sponsors & collaborators

University College, Londonlead sponsor

National Multiple Sclerosis Societycollaborator

Multiple Sclerosis Society of Great Britain and Northern Irelandcollaborator

Mapped research locations

LondonUnited Kingdom1 SheffieldUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01451593 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.